Cargando…

Human T cell lymphotropic virus type 1- associated infective dermatitis in KwaZulu Natal, South Africa

BACKGROUND: The Human T cell lymphotropic virus type 1 (HTLV-1)-associated infective dermatitis (IDH), is a chronic relapsing dermatitis which usually presents in children older than 2 years. A total of 300 cases have been reported worldwide (Latin America, the Caribbean and only 5 from Senegal). Ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Hlela, Carol, Graham, Natalie, Bhigjee, Ahmed I, Taylor, Graham P, Khumalo, Nonhlanhla P, Mosam, Anisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015614/
https://www.ncbi.nlm.nih.gov/pubmed/24152710
http://dx.doi.org/10.1186/1471-5945-13-11
_version_ 1782315364868161536
author Hlela, Carol
Graham, Natalie
Bhigjee, Ahmed I
Taylor, Graham P
Khumalo, Nonhlanhla P
Mosam, Anisa
author_facet Hlela, Carol
Graham, Natalie
Bhigjee, Ahmed I
Taylor, Graham P
Khumalo, Nonhlanhla P
Mosam, Anisa
author_sort Hlela, Carol
collection PubMed
description BACKGROUND: The Human T cell lymphotropic virus type 1 (HTLV-1)-associated infective dermatitis (IDH), is a chronic relapsing dermatitis which usually presents in children older than 2 years. A total of 300 cases have been reported worldwide (Latin America, the Caribbean and only 5 from Senegal). Neither IDH, nor its complications have been reported from the rest of Africa. We aimed to examine the clinical and aetiological characteristics of IDH in a cohort of South African children. METHODS: Attendees at the dermatology clinic at King Edward VIII Hospital, Durban underwent clinical examination. After obtaining consent those suspected of IDH had specimens taken for blood counts, immunoglobulins, serum protein electrophoresis, viral studies (including genotyping), skin swabs and stool examinations. RESULTS: Nineteen of 60 suspected cases recruited over 3 years met the diagnostic criteria for IDH. The male-to-female ratio was 1:2; mean age 8 years (range 0.7 to 15). Dermatitis mostly affected the scalp (78.9%) and axilla (73.7%); fewer children had nasal crusting (47.4%). Mean Ig A, IgG and IgM were raised, at 3.52 g/l, 22.6 g/l and 1.38 g/l, respectively. The median CD4 cell count was 1958 cells/mm(3). Viral genotyping of all tested samples were positive for the Cosmopolitan, Subtype A (HTLV-1a). CONCLUSIONS: IDH is a distinct entity which also affects South Africans. Our patients were older at presentation and the majority did not present with nasal crusting as has been described in other countries.
format Online
Article
Text
id pubmed-4015614
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40156142014-05-10 Human T cell lymphotropic virus type 1- associated infective dermatitis in KwaZulu Natal, South Africa Hlela, Carol Graham, Natalie Bhigjee, Ahmed I Taylor, Graham P Khumalo, Nonhlanhla P Mosam, Anisa BMC Dermatol Research Article BACKGROUND: The Human T cell lymphotropic virus type 1 (HTLV-1)-associated infective dermatitis (IDH), is a chronic relapsing dermatitis which usually presents in children older than 2 years. A total of 300 cases have been reported worldwide (Latin America, the Caribbean and only 5 from Senegal). Neither IDH, nor its complications have been reported from the rest of Africa. We aimed to examine the clinical and aetiological characteristics of IDH in a cohort of South African children. METHODS: Attendees at the dermatology clinic at King Edward VIII Hospital, Durban underwent clinical examination. After obtaining consent those suspected of IDH had specimens taken for blood counts, immunoglobulins, serum protein electrophoresis, viral studies (including genotyping), skin swabs and stool examinations. RESULTS: Nineteen of 60 suspected cases recruited over 3 years met the diagnostic criteria for IDH. The male-to-female ratio was 1:2; mean age 8 years (range 0.7 to 15). Dermatitis mostly affected the scalp (78.9%) and axilla (73.7%); fewer children had nasal crusting (47.4%). Mean Ig A, IgG and IgM were raised, at 3.52 g/l, 22.6 g/l and 1.38 g/l, respectively. The median CD4 cell count was 1958 cells/mm(3). Viral genotyping of all tested samples were positive for the Cosmopolitan, Subtype A (HTLV-1a). CONCLUSIONS: IDH is a distinct entity which also affects South Africans. Our patients were older at presentation and the majority did not present with nasal crusting as has been described in other countries. BioMed Central 2013-10-23 /pmc/articles/PMC4015614/ /pubmed/24152710 http://dx.doi.org/10.1186/1471-5945-13-11 Text en Copyright © 2013 Hlela et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Hlela, Carol
Graham, Natalie
Bhigjee, Ahmed I
Taylor, Graham P
Khumalo, Nonhlanhla P
Mosam, Anisa
Human T cell lymphotropic virus type 1- associated infective dermatitis in KwaZulu Natal, South Africa
title Human T cell lymphotropic virus type 1- associated infective dermatitis in KwaZulu Natal, South Africa
title_full Human T cell lymphotropic virus type 1- associated infective dermatitis in KwaZulu Natal, South Africa
title_fullStr Human T cell lymphotropic virus type 1- associated infective dermatitis in KwaZulu Natal, South Africa
title_full_unstemmed Human T cell lymphotropic virus type 1- associated infective dermatitis in KwaZulu Natal, South Africa
title_short Human T cell lymphotropic virus type 1- associated infective dermatitis in KwaZulu Natal, South Africa
title_sort human t cell lymphotropic virus type 1- associated infective dermatitis in kwazulu natal, south africa
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015614/
https://www.ncbi.nlm.nih.gov/pubmed/24152710
http://dx.doi.org/10.1186/1471-5945-13-11
work_keys_str_mv AT hlelacarol humantcelllymphotropicvirustype1associatedinfectivedermatitisinkwazulunatalsouthafrica
AT grahamnatalie humantcelllymphotropicvirustype1associatedinfectivedermatitisinkwazulunatalsouthafrica
AT bhigjeeahmedi humantcelllymphotropicvirustype1associatedinfectivedermatitisinkwazulunatalsouthafrica
AT taylorgrahamp humantcelllymphotropicvirustype1associatedinfectivedermatitisinkwazulunatalsouthafrica
AT khumalononhlanhlap humantcelllymphotropicvirustype1associatedinfectivedermatitisinkwazulunatalsouthafrica
AT mosamanisa humantcelllymphotropicvirustype1associatedinfectivedermatitisinkwazulunatalsouthafrica